In a environment where by well being and affordability collide, It is really hanging how Novo Nordisk's copyright happens to be a lifeline For a lot of. Although the manufacturing costs look realistic, the retail costs frequently depart you questioning the fairness of entry.California biotech behemoth Amgen ditched programs for an experimental weig